Vivanza Biosciences Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 28.08 million compared to INR 22.16 million a year ago. Revenue was INR 31.24 million compared to INR 25.74 million a year ago. Net income was INR 2.59 million compared to INR 2.07 million a year ago. Basic earnings per share from continuing operations was INR 0.65 compared to INR 0.52 a year ago. Diluted earnings per share from continuing operations was INR 0.65 compared to INR 0.52 a year ago. For the six months, sales was INR 30.35 million compared to INR 29.03 million a year ago. Revenue was INR 38.34 million compared to INR 32.64 million a year ago. Net income was INR 5.81 million compared to INR 0.383 million a year ago. Basic earnings per share from continuing operations was INR 1.45 compared to INR 0.1 a year ago. Diluted earnings per share from continuing operations was INR 1.45 compared to INR 0.1 a year ago.